440 related articles for article (PubMed ID: 11743354)
61. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
62. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
[TBL] [Abstract][Full Text] [Related]
63. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
[TBL] [Abstract][Full Text] [Related]
64. Thymidine phosphorylase and breast carcinoma.
Yang Q; Yoshimura G; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(4):2355-60. PubMed ID: 12174926
[TBL] [Abstract][Full Text] [Related]
65. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
66. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
67. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study.
Rofeim O; Hom D; Freid RM; Moldwin RM
J Urol; 2001 Jul; 166(1):134-6. PubMed ID: 11435840
[TBL] [Abstract][Full Text] [Related]
68. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
69. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Terao T
Hum Pathol; 2002 Nov; 33(11):1105-13. PubMed ID: 12454815
[TBL] [Abstract][Full Text] [Related]
70. Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma.
Oguri H; Maeda N; Yamamoto Y; Kusume T; Fukaya T
Cancer Chemother Pharmacol; 2004 Feb; 53(2):151-4. PubMed ID: 14614573
[TBL] [Abstract][Full Text] [Related]
71. Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors.
Yao Y; Kubota T; Sato K; Kitai R
Clin Cancer Res; 2001 Dec; 7(12):4021-6. PubMed ID: 11751496
[TBL] [Abstract][Full Text] [Related]
72. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
[TBL] [Abstract][Full Text] [Related]
73. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation.
Waxman JA; Sulak PJ; Kuehl TJ
J Urol; 1998 Nov; 160(5):1663-7. PubMed ID: 9783927
[TBL] [Abstract][Full Text] [Related]
74. Cystoscopy and bladder biopsies in patients with bladder pain syndrome carried out following ESSIC guidelines.
Wyndaele JJ; Van Dyck J; Toussaint N
Scand J Urol Nephrol; 2009; 43(6):471-5. PubMed ID: 19707951
[TBL] [Abstract][Full Text] [Related]
75. [Expression of thymidine phosphorylase in human colorectal carcinoma and its clinical significance].
Xiao JX; Sun H; Yang J; Li CL; Han M; Li R
Ai Zheng; 2004 Mar; 23(3):303-5. PubMed ID: 15025963
[TBL] [Abstract][Full Text] [Related]
76. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
Kim SH; Kim TB; Kim SW; Oh SJ
J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
[TBL] [Abstract][Full Text] [Related]
77. Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.
Gonzalez RR; Fong T; Belmar N; Saban M; Felsen D; Te A
J Urol; 2005 Feb; 173(2):630-4. PubMed ID: 15643278
[TBL] [Abstract][Full Text] [Related]
78. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.
Colaco M; Koslov DS; Keys T; Evans RJ; Badlani GH; Andersson KE; Walker SJ
J Urol; 2014 Oct; 192(4):1123-9. PubMed ID: 24840534
[TBL] [Abstract][Full Text] [Related]
79. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
[TBL] [Abstract][Full Text] [Related]
80. Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma.
Eder IE; Stenzl A; Hobisch A; Cronauer MV; Bartsch G; Klocker H
J Urol; 1996 Sep; 156(3):953-7. PubMed ID: 8709371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
